spacer
spacer

PDBsum entry 6d4t

Go to PDB code: 
Top Page protein ligands links
Oxidoreductase/oxidoreductase inhibitor PDB id
6d4t
Contents
Protein chain
331 a.a.
Ligands
IMP
FWS
Waters ×298

References listed in PDB file
Key reference
Title Synthesis and structure-Activity relationship of 1-(5-Isoquinolinesulfonyl)piperazine analogues as inhibitors of mycobacterium tuberculosis impdh.
Authors V.Singh, A.Pacitto, S.Donini, D.M.Ferraris, S.Boros, E.Illyés, B.Szokol, M.Rizzi, T.L.Blundell, D.B.Ascher, J.Pato, V.Mizrahi.
Ref. Eur J Med Chem, 2019, 174, 309-329. [DOI no: 10.1016/j.ejmech.2019.04.027]
PubMed id 31055147
Abstract
Tuberculosis (TB) is a major infectious disease associated increasingly with drug resistance. Thus, new anti-tubercular agents with novel mechanisms of action are urgently required for the treatment of drug-resistant TB. In prior work, we identified compound 1 (cyclohexyl(4-(isoquinolin-5-ylsulfonyl)piperazin-1-yl)methanone) and showed that its anti-tubercular activity is attributable to inhibition of inosine-5'-monophosphate dehydrogenase (IMPDH) in Mycobacterium tuberculosis. In the present study, we explored the structure-activity relationship around compound 1 by synthesizing and evaluating the inhibitory activity of analogues against M. tuberculosis IMPDH in biochemical and whole-cell assays. X-ray crystallography was performed to elucidate the mode of binding of selected analogues to IMPDH. We establish the importance of the cyclohexyl, piperazine and isoquinoline rings for activity, and report the identification of an analogue with IMPDH-selective activity against a mutant of M. tuberculosis that is highly resistant to compound 1. We also show that the nitrogen in urea analogues is required for anti-tubercular activity and identify benzylurea derivatives as promising inhibitors that warrant further investigation.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer